Galeterone
Galeterone (TOK-001) is a potent, orally active molecular glue degrader, which degrades androgen receptor (AR) and its splice variants (AR-Vs) and MAP kinase-interacting serine/threonine protein kinase Mnk1/2. Galeterone also functions as a CYP17 inhibitor (IC50 = 47 nM) . Galeterone induces cell apoptosis. Galeterone inhibits tumor growth in human prostate cancer xenograft mouse models. Galeterone can be used for castration resistant prostate cancer (CRPC) and pancreatic ductal adenocarcinoma (PDAC) research[1][2].
Product Specifications
CAS Number
851983-85-2
Product Name Alternative
TOK-001; VN-124-1
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Androgen Receptor; Apoptosis; Cytochrome P450; MNK; Molecular Glues
Type
Reference compound
Related Pathways
Apoptosis; MAPK/ERK Pathway; Metabolic Enzyme/Protease; PROTAC; Vitamin D Related/Nuclear Receptor
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/TOK-001.html
Purity
99.87
Solubility
DMSO : 25 mg/mL (ultrasonic)
Smiles
C[C@@]12C(N3C=NC4=CC=CC=C34)=CC[C@]1([C@@]5(CC=C6[C@@](C)([C@]5(CC2)[H])CC[C@@H](C6)O)[H])[H]
Molecular Formula
C26H32N2O
Molecular Weight
388.55
Precautions
H302, H315, H319, H335
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 3
Isoform
CYP17
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Recombinant Human Immunoglobulin kappa light chain (IGK), Biotinylated
Recombinant Human Immunoglobulin kappa light chain (IGK), Biotinylated
Recombinant Human Immunoglobulin kappa light chain (IGK), Biotinylated
Lentiviral human ADGRF2 shRNA (UAS) - Lentiviral human ADGRF2 shRNA (UAS, RFP) plasmid